Kristian G. AndersenGeverifieerd account

Ha ha ha. Love it

Back in May, we re-analyzed all of the available SRA Guangdong pangolin CoV data. I'm confident we have the most comprehensive and reproducible data set regarding this CoV. For better or for worse, we've left the decision up to an editor whether our analysis should be published.

Which editor?

No one is more impatient and patient than we are right now. We are striving to be respectful while firm in our opinion that our analysis of the GD pangolin CoV needs to be published as a proper scientific manuscript, not only as tweets or a preprint.

Lam builds their GD pangolin CoV seq (with the highly identical RBD to SARS2) using metagenomic data from Liu 2019 Viruses. Xiao also uses the same metagenomic data from Liu 2019 Viruses. The situation becomes very clear once you access the data in the 3 SRAs.

In our manuscript, we break down the reads per sample to show where the sequences are actually coming from. It's a bit frustrating that we've been under editorial consideration for 3 weeks... I promise it will become as clear as day as soon as it is published.

I have been privately sharing our manuscript with scientists who are using the Liu MP789 or Xiao GISAID genome in their analysis so that they can make informed decisions. I am happy to do that if you're interested. I don't believe in holding back impt findings.